Wird geladen...
Fulfilling the Promise of "Biased" G Protein–Coupled Receptor Agonism
The fact that over 30% of current pharmaceuticals target heptahelical G protein–coupled receptors (GPCRs) attests to their tractability as drug targets. Although GPCR drug development has traditionally focused on conventional agonists and antagonists, the growing appreciation that GPCRs mediate phys...
Gespeichert in:
| Veröffentlicht in: | Mol Pharmacol |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
The American Society for Pharmacology and Experimental Therapeutics
2015
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4551052/ https://ncbi.nlm.nih.gov/pubmed/26134495 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1124/mol.115.099630 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|